High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis.
| Image |  |
|---|---|
| Description | scientific article published on 30 March 2018 |
| Author/s |
author: Thenappan Chandrasekar Hanan Goldberg |
| Publication date | March 30, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |